Next Article in Journal / Special Issue
Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on “Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199”
Previous Article in Journal
The HSV1 Tail-Anchored Membrane Protein pUL34 Contains a Basic Motif That Supports Active Transport to the Inner Nuclear Membrane Prior to Formation of the Nuclear Egress Complex
Previous Article in Special Issue
Maternal and Neonatal Outcomes of SARS-CoV-2 Infection in a Cohort of Pregnant Women with Comorbid Disorders
 
 
Reply published on 5 August 2021, see Viruses 2021, 13(8), 1546.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Comment

Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199

by
Serge Stroobandt
1 and
Roland Stroobandt
2,*
1
Independent Researcher, Kolonel Dusartplein 10, 3500 Hasselt, Belgium
2
Vaccination Center Oostende-Bredene, 8400 Oostende, Belgium
*
Author to whom correspondence should be addressed.
Viruses 2021, 13(8), 1545; https://doi.org/10.3390/v13081545
Submission received: 13 July 2021 / Accepted: 30 July 2021 / Published: 5 August 2021
(This article belongs to the Special Issue Emerging Virus Infections in Adverse Pregnancy Outcomes)
Dr. Sarah Stuckelberger and her colleagues should be commended for their cross-sectional study assessing the willingness of Swiss pregnant and breastfeeding women to be vaccinated against SARS-CoV-2 [1]. They emphasise the need to identify and reduce barriers towards immunisation. Furthermore, they express the hope that when more data become available about vaccinated pregnant women, willingness to be vaccinated will increase. Moreover, the authors refer to a study [2] that has been unequivocally heralded as a proof of safety for the use of COVID-19 mRNA vaccines in pregnant women.
Regardless, we would like to advise readers that the referenced article contains a serious error regarding the interpretation of the data presented in Table 4. Prospective cohort studies are routinely performed to establish the safety of novel obstetric interventions. Such studies typically compare, at the same gestational age, the wellbeing of a cohort that underwent the intervention to that of a comparable control cohort (or, in the absence of this, the pertaining population) without the intervention. Nonetheless, the cited study compared the control population’s incidence rate of spontaneous abortions of 10 to 26% prior to week 20 to the incidence among the 827 study participants of which 700 received their first dose only in the third trimester, i.e., after week 26. However, a correct comparison with the remaining 127 participants sets the 104 spontaneous abortions recorded prior to week 20 at an alarming incidence of 82%, i.e., 3 to 8 times higher than in the control population. This observation suggests that obstetric vaccine safety is severely compromised during pregnancy and may lead to decreased willingness among pregnant women to be vaccinated.

Author Contributions

Both authors contributed equally to this paper. All authors have read and agreed to the published version of the manuscript.

Funding

The authors received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Stuckelberger, S.; Favre, G.; Ceulemans, M.; Nordeng, H.; Gerbier, E.; Lambelet, V.; Stojanov, M.; Winterfeld, U.; Baud, D.; Panchaud, A.; et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199. [Google Scholar] [CrossRef] [PubMed]
  2. Shimabukuro, T.T.; Kim, S.Y.; Myers, T.R.; Moro, P.L.; Oduyebo, T.; Panagiotakopoulos, L.; Marquez, P.L.; Olson, C.K.; Liu, R.; Chang, K.T.; et al. Preliminary Findings of mRNA COVID-19 Vaccine Safety in Pregnant Persons. N. Engl. J. Med. 2021, 384, 2273–2282. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199. Viruses 2021, 13, 1545. https://doi.org/10.3390/v13081545

AMA Style

Stroobandt S, Stroobandt R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199. Viruses. 2021; 13(8):1545. https://doi.org/10.3390/v13081545

Chicago/Turabian Style

Stroobandt, Serge, and Roland Stroobandt. 2021. "Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199" Viruses 13, no. 8: 1545. https://doi.org/10.3390/v13081545

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop